Stephen Feider, Chief Financial Officer at Beta Bionics, Inc. (BBNX), sold 8,810 shares at $21.52 ($190K) on 2025-10-03, disclosed to the SEC on 2025-10-07.
Scheduled sale ($190k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.52 | 3,828 | $82K | 43.3% |
| 2 | $21.52 | 3,828 | $82K | 43.3% |
| 3 | $22.28 | 1,154 | $26K | 13.5% |
| Total | $21.62 avg | 8,810 | $190K | 100% |
| Filing → |
| BBNX | SELL | 2026-06-03 | $84K | — | Filing → |
| BBNX | SELL | 2026-03-03 | $18K | — | Filing → |
| BBNX | SELL | 2026-01-05 | $591K | — | Filing → |